245 related articles for article (PubMed ID: 31280356)
21. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
[TBL] [Abstract][Full Text] [Related]
22. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
[TBL] [Abstract][Full Text] [Related]
23. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
[TBL] [Abstract][Full Text] [Related]
24. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.
Fan J; Cao H; Su L; Ling Z; Liu Z; Lan X; Xu Y; Chen W; Yin Y
J Interv Card Electrophysiol; 2012 Jan; 33(1):93-100. PubMed ID: 21938519
[TBL] [Abstract][Full Text] [Related]
25. Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
Oyama K; Giugliano RP; Berg DD; Ruff CT; Jarolim P; Tang M; Murphy SA; Lanz HJ; Grosso MA; Antman EM; Braunwald E; Morrow DA
Eur Heart J; 2021 May; 42(17):1698-1706. PubMed ID: 33760027
[TBL] [Abstract][Full Text] [Related]
26. NT-proBNP is associated with mortality and adverse cardiac events in patients with atrial fibrillation presenting to the emergency department.
Holl MJ; van den Bos EJ; van Domburg RT; Fouraux MA; Kofflard MJ
Clin Cardiol; 2018 Mar; 41(3):400-405. PubMed ID: 29480582
[TBL] [Abstract][Full Text] [Related]
27. Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation.
Niederdöckl J; Simon A; Schnaubelt S; Schuetz N; Laggner R; Sulzgruber P; Spiel AO; Herkner H; Laggner AN; Domanovits H
Heart; 2019 Mar; 105(6):482-488. PubMed ID: 30415208
[TBL] [Abstract][Full Text] [Related]
28. Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort.
Li L; Selvin E; Lutsey PL; Hoogeveen RC; O'Neal WT; Soliman EZ; Chen LY; Alonso A
Am Heart J; 2018 Oct; 204():119-127. PubMed ID: 30099337
[TBL] [Abstract][Full Text] [Related]
29. Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.
Almuwaqqat Z; O'Neal WT; Norby FL; Lutsey PL; Selvin E; Soliman EZ; Chen LY; Alonso A
J Am Heart Assoc; 2019 Oct; 8(19):e013294. PubMed ID: 31564186
[TBL] [Abstract][Full Text] [Related]
30. N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure.
Schnorbach J; Fröhlich H; Täger T; Corletto A; Katus HA; Frankenstein L
ESC Heart Fail; 2019 Aug; 6(4):640-648. PubMed ID: 31259484
[TBL] [Abstract][Full Text] [Related]
31. Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.
Hwang HJ; Son JW; Nam BH; Joung B; Lee B; Kim JB; Lee MH; Jang Y; Chung N; Shim WH; Cho SY; Kim SS
Clin Res Cardiol; 2009 Apr; 98(4):213-8. PubMed ID: 19229464
[TBL] [Abstract][Full Text] [Related]
32. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
[TBL] [Abstract][Full Text] [Related]
33. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study.
Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
Circulation; 2011 May; 123(19):2101-10. PubMed ID: 21536998
[TBL] [Abstract][Full Text] [Related]
34. CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation.
Wakula P; Neumann B; Kienemund J; Thon-Gutschi E; Stojakovic T; Manninger M; Scherr D; Scharnagl H; Kapl M; Pieske B; Heinzel FR
Europace; 2017 Apr; 19(4):544-551. PubMed ID: 28431065
[TBL] [Abstract][Full Text] [Related]
35. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
[TBL] [Abstract][Full Text] [Related]
36. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
Zhu ZD; Sun T
Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
[TBL] [Abstract][Full Text] [Related]
37. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
Sharma A; Hijazi Z; Andersson U; Al-Khatib SM; Lopes RD; Alexander JH; Held C; Hylek EM; Leonardi S; Hanna M; Ezekowitz JA; Siegbahn A; Granger CB; Wallentin L
Circulation; 2018 Oct; 138(16):1666-1676. PubMed ID: 29871978
[TBL] [Abstract][Full Text] [Related]
38. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation.
Fu S; Jiao J; Guo Y; Zhu B; Luo L
BMC Geriatr; 2019 Feb; 19(1):56. PubMed ID: 30819103
[TBL] [Abstract][Full Text] [Related]
39. N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity.
Patton KK; Heckbert SR; Alonso A; Bahrami H; Lima JA; Burke G; Kronmal RA
Heart; 2013 Dec; 99(24):1832-6. PubMed ID: 24131775
[TBL] [Abstract][Full Text] [Related]
40. Association between the N-terminal plasma brain natriuretic peptide levels or elevated left ventricular filling pressure and thromboembolic risk in patients with non-valvular atrial fibrillation.
Yu GI; Cho KI; Kim HS; Heo JH; Cha TJ
J Cardiol; 2016 Aug; 68(2):110-6. PubMed ID: 26775889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]